Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study.
Miao WangHan-Yu CaoKai-Wen TanQiao-Cheng QiuYuan-Hong HuangShuai-Shuai GeZi-Hao WangJia ChenXiao-Wen TangDe-Pei WuSheng-Li XueZheng LiHai-Ping DaiPublished in: Blood cancer journal (2023)